U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.
about
P1343
Cooperative epigenetic modulation by cancer amplicon genesFibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells.TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.3D imaging of telomeres and nuclear architecture: An emerging tool of 3D nano-morphology-based diagnosis.Cellular localization and processing of primary transcripts of exonic microRNAs.Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacityLMP1 mediates multinuclearity through downregulation of shelterin proteins and formation of telomeric aggregates.The c-Rel Transcription Factor in Development and Disease.Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma.Three-dimensional Telomere Signatures of Hodgkin- and Reed-Sternberg Cells at Diagnosis Identify Patients with Poor Response to Conventional ChemotherapyDisruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells.Alterations of the CD58 gene in classical Hodgkin lymphoma.MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma.3D nuclear organization of telomeres in the Hodgkin cell lines U-HO1 and U-HO1-PTPN1: PTPN1 expression prevents the formation of very short telomeres including "t-stumps".Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application.Fine tuning of FOXO3A in cHL as a survival mechanism and a hallmark of abortive plasma cell differentiation.
P2860
Q24608701-501600B8-A15C-42C5-A60A-DAA61A57CC4FQ30449589-D5A6212D-FA20-42A9-91CD-E59F015B8EF4Q30560427-10482724-3FDF-4A45-96AB-DF872D9F9B67Q33432504-2DA015D4-8258-472D-AD52-303AFACE7729Q33698325-DB2D8CB9-C85B-436F-BE2C-3E9E9452848EQ35000982-983610D3-7EEB-4320-BA48-75F9B74263B1Q35078505-2E30A1E7-5AF0-462F-B36E-0B6ED47BAFC0Q35539719-262B8A76-F199-44E2-95D7-F2FBF9E0F9DAQ35556506-2E41C8FC-E933-4CD3-AF0A-0E3DC6372E8EQ35944671-92499B34-610E-4673-980F-9D1A0A881C1FQ36199852-BF195172-4448-462D-BEB4-68074379D1BFQ38706339-2E4471F5-6BF4-4244-B107-DC85F2BF34C8Q38851024-CAAAFBB6-E85C-4BAD-AB42-D7BD4B69ADB1Q39467028-880C13BE-315E-4738-8A54-4A20EDCDB4D1Q39622256-F2A5BADA-6EBB-4160-B7EF-4C3E4DBCEC30Q39889779-95483BBF-DA07-4231-8098-4FC806BC9449Q42204673-F1040D09-6EDB-41CB-85DE-76358D385953Q50028326-1BBE0DD4-399B-4B6C-BCED-E2F52D08F452
P2860
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.
@en
type
label
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.
@en
prefLabel
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.
@en
P2093
P356
P1476
U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.
@en
P2093
H K Muller-Hermelink
S Bruderlein
P2860
P304
P356
10.1159/000112062
P4510
P577
2007-01-01T00:00:00Z